CARLSBAD, Calif., Oct. 12, 2011 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced the Applied Biosystems QuantStudio™ 12K Flex Real-Time PCR system, a highly versatile genetic analysis instrument that enables cost-effective and efficient interrogation of hundreds of target genes over thousands of samples in a single run.
The growing demand of biomarker screening experiments, particularly in the early research phases of pharmacogenomics and agricultural biotechnology fields, has created a greater need for high-throughput technology that can provide answers for researchers faster, more accurately and at a reasonable price per reaction.
The QuantStudio™ 12K Flex system addresses this with its ability to generate more than 12,000 high-quality, TaqMan® data points per run, or up to 110,000 data points in an eight-hour workday. Users can also run digital PCR experiments on the instrument using nanofluidic consumables and dedicated analysis software for increased sensitivity and specificity.
"The QuantStudio provides an excellent solution for accurate, high-throughput and cost-effective genotyping, which is critical to the success of research in my laboratory," said Nathan Treff, Ph.D., Director of Molecular Biology at Reproductive Medicine Associates of New Jersey. "This all-in-one device is a perfect streamlined solution to make rapid progress toward our primary objective of improving the success of in vitro fertilization. The QuantStudio will simplify our workflow and reduce the amount of time spent on generating data."
Cost Effective, Minimal Hands-On Time
Applications such as pharmacogenomic testing, for example, are enabled at a more cost-efficient price
|SOURCE Life Technologies Corporation|
Copyright©2010 PR Newswire.
All rights reserved